Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2016 (LINC02016) is a member of the **long intergenic non-coding RNA (lincRNA)** family, defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes[1][3]. LincRNAs are a subclass of long non-coding RNAs generally implicated in regulating gene expression by mechanisms including chromatin remodeling, transcriptional regulation, and cellular architecture, although only a small fraction of annotated lincRNAs have been functionally characterized[1]. For LINC02016 specifically, there are currently no experimentally established biological functions, disease associations, or evidence that it serves as a therapeutic target or biomarker[3]. No drugs target or modulate this lincRNA, and there is no specific literature ascribing it a role in known molecular pathways or disease processes. It is cataloged in gene databases (NCBI Gene ID: 101927123, Ensembl: ENSG00000244215) as a human non-protein-coding gene[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2016 (LINC02016).